Questa Capital
Questa Capital is a healthcare-focused growth-equity firm investing in healthcare services, healthcare technology, and medical devices.
- Healthcare and life sciences private equity investment firm
- Healthcare & Life Sciences PEF
- Tier III
Overview
Questa Capital is a healthcare-focused growth-equity firm investing in healthcare services, healthcare technology, and medical devices.
The firm backs commercial-stage companies with scalable business models and products or services intended to improve care, efficiency, safety, or patient experience. Its concentrated investment approach gives each portfolio company meaningful institutional attention. Within The Economy Wiki, the firm is connected to the Healthcare & Life Sciences PEF market category.
Firm facts
| Institution | Questa Capital |
| Type | Healthcare and life sciences private equity investment firm |
| Headquarters | Washington, D.C., and San Francisco, United States |
| Founded | 2016 |
| Primary ranking focus | Healthcare & Life Sciences PEF |
| Highest 2026 tier | Tier III |
Activities and investment capabilities
Questa’s focus sits between venture capital and traditional buyouts. Portfolio companies generally possess market validation but require capital and strategic support to accelerate growth, develop management teams, expand geographically, or reach the scale needed for a strategic or sponsor-backed exit.
Healthcare investing
Equity investment across healthcare services, products and technology.
Life sciences exposure
Capital for pharmaceutical, biotechnology, medtech and outsourced-service platforms.
Sector value creation
Support informed by regulation, reimbursement, clinical workflows and market access.
Strategy and transaction coverage
Strategy and sector coverage
Healthcare services; life sciences; pharmaceuticals; medtech; diagnostics; healthcare IT
Transaction and ownership contexts
Buyouts; growth investments; recapitalizations; platform formation; add-on acquisitions
Market position
Questa Capital fits Tier III because it has developed a credible healthcare-only growth platform with approximately $1 billion under management and clear specialization across services, technology, and devices.
Questa Capital is assessed within the Healthcare & Life Sciences PEF framework. For wider market context, see The Mid-Market Advantage in Healthcare Private Equity.
Competitive context
Questa Capital is recognized Tier III in Top 30 Healthcare & Life Sciences PEF 2026. The ranking compares firms by institutional relevance, specialist capability, investment activity, operating depth and market positioning. Comparable-firm links below support navigation and do not imply that every institution competes for every transaction or asset.
Leadership and governance
Leadership, investment-committee composition and operating resources may change over time. Current information should be confirmed through Questa Capital’s official website.
| Leadership area | Current source |
|---|---|
| Investment and operating leadership | Current team and governance information |
Corporate and public information
This profile refers to Questa Capital as the public-facing investment organization. Individual funds, management companies, advisers and regulated entities may use separate legal names across jurisdictions.
Corporate and disclosure information
| Organization | Questa Capital |
| Headquarters | Washington, D.C., and San Francisco, United States |
| Public website | www.questacapital.com |
| Profile basis | Public institutional information and Capital Ranking editorial research |
Ranking recognition
Related Economy analysis
Selected Economy Markets articles provide context for the investment, diligence, financing and value-creation themes relevant to this firm:
- The Mid-Market Advantage in Healthcare Private Equity
- Middle-Market Private Equity: Returns, Scale and Manager Selection
- Private Equity Technology Due Diligence in the AI Era
